The Resistant Depression Response to Esketamine Assessing Metabolomics (ReDREAM) Project— Untargeted Metabolomics to Identify Biomarkers of Treatment Response to Intranasal Esketamine in Individuals with Treatment-Resistant Depression: A Study Protocol
Francesco Bartoli, Daniele Cavaleri, Ilaria Riboldi, Cristina Crocamo, Renato de Filippis, Riccardo Zandonella Callegher, Giuseppe Paglia, Umberto Albert, Pasquale De Fazio, Giuseppe Carrà
(Alpha Psychiatry 2024; 25: 555-560) DOI: 10.5152/alphapsychiatry.2024.241549